Published February 8, 2018
| Version v1
Patent
Open
BETA-CATENIN INHIBITORS IN CANCER IMMUNOTHERAPY
Contributors
Patent applicant:
Description
Provided herein are compositions and methods for the treatment of cancer by inhibition of β-catenin or a β-catenin pathway. In particular, inhibitors of β-catenin and/or the Wnt/p-catenin signaling pathway are employed prevent or reverse evasion of immune response or immuno-therapy by cancers.
Files
US20180038868.pdf
Files
(3.4 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:5e95b5aa07bdebbc2e7fae3fe318bc59
|
3.4 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 201615555099 A
- Patent number
- US 10753938 B2
- Other
- oai:uchicago.tind.io:7912
Dates
- Patent filed
-
2016-03-04